A Three-Week, Double-Blind, Multicenter, Placebo-Controlled Study Evaluating the Efficacy and Safety of Add-On Oral Ziprasidone in Subjects With Acute Mania Treated With Lithium or Divalproex.
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2013
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- Sponsors Pfizer
- 14 Mar 2013 Primary endpoint 'Young-Mania-Rating-Scale' has not been met.
- 24 Mar 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History